Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Using proximity biotinylation coupled to mass spectrometry to characterize the role of cytoskeleton-derived signals in colorectal cancer oncogenesis
EF 2017-18
Résumé
Determining the Impact of the Hippo Pathway on Colorectal Cancer Growth Colorectal (bowel) cancers are formed when cells ignore commands to stop growing and multiplying. Like runners passing a baton in a relay race, proteins pass signals (messages) from outside the cell to the nucleus where growth is switched on or off. For example, the Hippo pathway tells the cell to stop growing when it senses that its surroundings are too crowded. Without this pathway, our organs would be too large. Tumors can form when protein messengers are mutated and do not tell the cell to stop growing. How such mutations lead to colorectal cancers is still largely unknown. Thus, these mutations are important to study since colorectal cancer is the second most diagnosed cancer in Canadians.
I plan to study how signals are passed along the Hippo pathway from outside the cell to the nucleus through the cytoskeleton (structure that helps the cell keep its shape). I hypothesize that we will be able to find new treatments for colorectal cancer by understanding how mutations in messenger proteins prevent external signals from telling the cell to stop growing and dividing. Hence, I will use tools for studying proteins to figure out which messengers are involved in this signal relay. By mapping out a network of messengers, I will be able to see which mutations prevent signals from being properly transferred in colorectal cancer cells. Understanding this network is important because it may uncover new ways to treat colorectal cancers.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
386355
Name
Abe Kento T
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Using proximity biotinylation coupled to mass spectrometry to characterize the role of cytoskeleton-derived signals in colorectal cancer oncogenesis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioid; Colorectal Cancer; Cytoskeleton; Hippo Pathway; Mass Spectrometry; Proteomics; Signal Transduction; Systems Biology
Abstract
Determining the Impact of the Hippo Pathway on Colorectal Cancer Growth Colorectal (bowel) cancers are formed when cells ignore commands to stop growing and multiplying. Like runners passing a baton in a relay race, proteins pass signals (messages) from outside the cell to the nucleus where growth is switched on or off. For example, the Hippo pathway tells the cell to stop growing when it senses that its surroundings are too crowded. Without this pathway, our organs would be too large. Tumors can form when protein messengers are mutated and do not tell the cell to stop growing. How such mutations lead to colorectal cancers is still largely unknown. Thus, these mutations are important to study since colorectal cancer is the second most diagnosed cancer in Canadians.
I plan to study how signals are passed along the Hippo pathway from outside the cell to the nucleus through the cytoskeleton (structure that helps the cell keep its shape). I hypothesize that we will be able to find new treatments for colorectal cancer by understanding how mutations in messenger proteins prevent external signals from telling the cell to stop growing and dividing. Hence, I will use tools for studying proteins to figure out which messengers are involved in this signal relay. By mapping out a network of messengers, I will be able to see which mutations prevent signals from being properly transferred in colorectal cancer cells. Understanding this network is important because it may uncover new ways to treat colorectal cancers.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Abe, Kento T
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~